Dimerization of human 5-lipoxygenase.

Area of Science:

• Biochemistry
• Enzymology
• Molecular Biology

Background:

• Human 5-lipoxygenase (5-LO) is a key enzyme in inflammatory pathways.
• The oligomeric state of 5-LO can influence its catalytic activity.
• Understanding 5-LO dimerization is crucial for developing targeted therapeutics.

Purpose of the Study:

• To investigate the dimerization of human 5-lipoxygenase (5-LO).
• To determine the effect of glutathionylation and diamide treatment on 5-LO oligomeric state and activity.
• To identify the protein-protein interaction domains involved in 5-LO dimerization.

Main Methods:

• Native gel electrophoresis
• Gel filtration chromatography
• LILBID mass spectrometry
• Bioinformatic analysis
• Molecular modeling
• Site-directed mutagenesis (Cys to Ser mutations)

Main Results:

• Human 5-LO forms dimers, detectable by multiple biophysical techniques.
• Glutathionylation of 5-LO leads to a monomeric form with full catalytic activity.
• Diamide treatment induces disulfide-bridged dimers and inactive oligomers.
• Bioinformatic and modeling studies suggest a head-to-tail dimer interface, involving specific cysteine residues.
• Mutating key cysteines (C159S, C300S, C416S, C418S) prevented diamide-induced dimerization and activity loss.

Conclusions:

• 5-lipoxygenase (5-LO) exists as a dimer, and its oligomeric state is modulated by post-translational modifications.
• Glutathionylation promotes an active monomeric state, while diamide induces inactive oligomers.
• A specific dimer interface involving key cysteines regulates 5-LO activity and oligomerization.